Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Drug Discovery & Development

John Watson's Biography



John Watson, Director, Promega Corporation

Dr. Watson has a B.S. in Genetics and Cell Biology from the University of Minnesota, an M.S. in Bacteriology; and a Ph.D. in Biomolecular Chemistry from the University of Wisconsin. After a clinical postdoctoral fellowship in Clinical Chemistry and Molecular Diagnostics he became Director of Molecular Diagnostics at Epicentre Technologies where he led R&D and Marketing efforts for their clinical products. Subsequent positions have included Director of Cellular Analysis at Promega Corporation, and Director of Marketing for the PanVera division Vertex Pharmaceuticals (becoming Director of Marketing for Drug Screening at Invitrogen after the acquisition). He also managed R&D, applications and Marketing for the FTIR instrument division of Thermo Electron Corporation.

John Watson Image

Using In Vitro Screening Assays to Profile the Biology of Chemical Entities

Wednesday, 31 October 2012 at 11:45

Add to Calendar ▼2012-10-31 11:45:002012-10-31 12:45:00Europe/LondonUsing In Vitro Screening Assays to Profile the Biology of Chemical EntitiesSELECTBIOenquiries@selectbiosciences.com

In vitro assays can be used in early drug discovery to help shape chemical leads into molecules with increased likelihood of success in vivo.


Add to Calendar ▼2012-10-30 00:00:002012-10-31 00:00:00Europe/LondonDrug Discovery and DevelopmentSELECTBIOenquiries@selectbiosciences.com